Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
If deployed effectively and equitably, this latest generation of vaccines could help to prevent countless deaths and hospitalizations among the young and old.
Scientists are racing to control malaria in northern Brazil where the disease is playing a major part in the current health emergency threatening the region’s Indigenous people.
Concerns that artemisinin combination treatments are losing their effectiveness against Plasmodium parasites have set scientists looking for alternatives.
Hot on the heels of the first approved vaccine for malaria, researchers are racing to develop even better shots that tackle the parasite at every stage of its life cycle.
Immunologist Robert Seder and malaria epidemiologist Kassoum Kayentao talk to Nature about their work and how they think the parasitic disease could be controlled in the future.
Gene-drive technology that can spread antimalarial modifications throughout mosquito populations is maturing, but there are questions to answer before it can be used in the wild.
Efforts to discourage new smokers and help people to quit are bringing smoking rates down in many places, but it’s going to take more to put an end to tobacco smoking altogether.
Repetitive transcranial magnetic stimulation is already approved to help people overcome addiction to cigarettes, but researchers still have a lot to learn about how to deliver the treatment effectively.
As e-cigarettes grow in popularity, the lack of knowledge about whether nicotine contributes to the damaging health effects of smoking is becoming more worrying.